Patents by Inventor Paul Markham

Paul Markham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic Antibody Formulations
    Publication number: 20230322913
    Abstract: Stable pharmaceutical formulations for therapeutic anti-IL-23p19 antibodies and methods of using such stable pharmaceutical formulations.
    Type: Application
    Filed: September 10, 2021
    Publication date: October 12, 2023
    Inventors: Aaron Paul Markham, Galen Huaiqiu Shi, Justin Cody Thomas
  • IL-17 antibody formulations and methods of treatment using same
    Patent number: 10472416
    Abstract: The present invention provides pharmaceutical formulations for anti-IL-17 antibodies. These anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: November 12, 2019
    Assignee: Eli Lilly and Company
    Inventors: Vincent John Corvari, Barbara Ann Williams, Patrick Daniel Donovan, Aaron Paul Markham
  • IL-17 ANTIBODY FORMULATION
    Publication number: 20180057584
    Abstract: The present invention provides pharmaceutical formulations for anti-IL-17 antibodies. These anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing psoriatic arthritis or multiple myeloma.
    Type: Application
    Filed: November 10, 2017
    Publication date: March 1, 2018
    Inventors: Vincent John Corvari, Barbara Ann Williams, Patrick Daniel DONOVAN, Aaron Paul MARKHAM
  • IL-17 antibody formulations and methods of treatment using same
    Patent number: 9845353
    Abstract: The present invention provides stabilized pharmaceutical formulations for anti-IL-17 antibodies, comprising e.g. citrate, sodium chloride and polysorbate-80 at pH 5.7. These stabilized anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: December 19, 2017
    Assignee: Eli Lilly and Company
    Inventors: Vincent John Corvari, Barbara Ann Williams, Patrick Daniel Donovan, Aaron Paul Markham
  • IL-17 ANTIBODY FORMULATION
    Publication number: 20160280781
    Abstract: The present invention provides stabilized pharmaceutical formulations for anti-IL-17 antibodies, comprising e.g. citrate, sodium chloride and polysorbate-80 at pH 5.7. These stabilized anti-EL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
    Type: Application
    Filed: June 10, 2016
    Publication date: September 29, 2016
    Inventors: Vincent John Corvari, Barbara Ann Williams, Patrick Daniel DONOVAN, Aaron Paul MARKHAM
  • IL-17 antibody formulation and method of treatment using same
    Patent number: 9376491
    Abstract: The present invention provides stabilized pharmaceutical formulations for anti-IL-17 antibodies, comprising e.g. citrate, sodium chloride and polysorbate-80 at pH 5.7. These stabilized anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: June 28, 2016
    Assignee: Eli Lilly and Company
    Inventors: Vincent John Corvari, Barbara Ann Williams, Patrick Daniel Donovan, Aaron Paul Markham
  • IL-17 ANTIBODY FORMULATION
    Publication number: 20150010573
    Abstract: The present invention provides stabilized pharmaceutical formulations for anti-IL-17 antibodies, comprising e.g. citrate, sodium chloride and polysorbate-80 at pH 5.7. These stabilized anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
    Type: Application
    Filed: March 1, 2013
    Publication date: January 8, 2015
    Applicant: Eli Lilly and Company
    Inventors: Vincent John Corvari, Barbara Ann Williams, Patrick Daniel Donovan, Aaron Paul Markham
  • Kiosk
    Patent number: D286432
    Type: Grant
    Filed: April 11, 1984
    Date of Patent: October 28, 1986
    Inventor: Paul Markham